ADM GER Week ended 24 Jul 2026

Weekly Investor Report

Archer-Daniels-Midland Company · Consumer Defensive · Farm Products

Open interactive chart View report data
Latest close 76.00 EUR
1.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 22.1% above the Trend Line and sits at 95.6% of its 52-week range. The latest completed week returned 1.8%, after a 12.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.

Setup score 78 out of 100
Latest Close 76.00 EUR 24 Jul 2026
1W Return 1.8% latest completed week
4W Return 12.1% short-term follow-through
12W Return 18.8% quarterly tape
Trend Breadth 98.1% 51 of 52 weeks active
Volume Ratio 2.3x vs 13-week average
What is working
  • The trend backdrop is active with a 51-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 43.85% based on similar historical setup states.
  • 4 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.8% Latest completed week; four-week move 12.1%. Indicator stack 99/78 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.85% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 0 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 22.1% above the Trend Line and sits at 95.6% of its 52-week range. The latest completed week returned 1.8%, after a 12.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8412-week average 0.80

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.84Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 12.1% over four weeks, 18.8% over 12 weeks, and 65.4% over one year. The current trend has remained active for 51 consecutive weeks.

Performance by holding period

1W1.8%
4W12.1%
12W18.8%
26W36.1%
52W65.4%
Active trend streak51 weeks
Active weeks in one year51
Trend breadth98.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.11Latest activity-pressure read.
Pressure change95.8%Four-week change in activity pressure.
Leadership28.60Latest relative-leadership reading.
RS change39.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength38/100Blend of value, momentum, and quality. Underlying universe rank 63; rank 1 is best.
Value41/100Relative valuation strength. Underlying universe rank 60; rank 1 is best.
Quality12/100Profitability and accounting quality. Underlying universe rank 89; rank 1 is best.
Momentum88/100Medium-term price momentum. Underlying universe rank 13; rank 1 is best.
Growth4/100Revenue and earnings growth. Underlying universe rank 97; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework8/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
33.9x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
14.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
6.3%
Gross profit retained from each unit of revenue.
Operating margin
1.8%
Operating profit retained from revenue.
Free-cash-flow margin
5.9%
Free cash flow generated from revenue.
Return on invested capital
3.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-6.2%
Latest one-year revenue growth.
EPS growth
-40.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
242.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.4%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

0 positive · 0 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.8%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+9.7%Week of 13 Mar.
Worst week-8.9%Week of 20 Mar.
Latest week+1.8%Week of 24 Jul.

Shape of recent returns

Strong gains10
Modest gains4
Flat weeks0
Modest losses7
Sharp losses5
Recent vol4.1%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew4.2% / -2.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryDE Farm Products
4-week rank1 / 2
Group average6.8%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership

Four-week leaders

ADM · GER12.1%GTK · GER1.4%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape77/100

Trend, activity pressure, participation, and risk combine to a 77/100 tape read.

 Indicator analysis81/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.84; 4 reversal markers Next-Week ExpectancyNegative 43.85%

Next-week expectancy is negative with a 43.85% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors42/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 56; Small Cap Core rank 53 SVQF8/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 342.5 of 372 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 0 relevant articles.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202676.00 EUR1.8%62.23 EUR53.04 EUR1.1128.604.8KOn
17 Jul 202674.62 EUR6.8%61.30 EUR53.00 EUR0.7128.825.0KOn
10 Jul 202669.90 EUR4.1%60.45 EUR52.95 EUR0.2420.692.5KOn
3 Jul 202667.12 EUR-1.0%59.80 EUR52.91 EUR0.2913.582.6KOn
26 Jun 202667.78 EUR4.2%59.23 EUR52.88 EUR0.5720.571.3KOn
19 Jun 202665.06 EUR-5.3%58.69 EUR52.84 EUR0.7115.210On
12 Jun 202668.68 EUR-4.2%58.21 EUR52.81 EUR0.9324.061.1KOn
5 Jun 202671.72 EUR4.4%57.54 EUR52.77 EUR1.0529.98820On
29 May 202668.68 EUR2.6%56.73 EUR52.69 EUR0.9224.09736On
22 May 202666.94 EUR-2.4%56.15 EUR52.64 EUR0.7623.111.6KOn
15 May 202668.55 EUR5.1%55.69 EUR52.60 EUR0.4632.143.2KOn
8 May 202665.24 EUR2.0%55.16 EUR52.55 EUR0.0224.953.2KOn
1 May 202663.99 EUR9.3%54.69 EUR52.52 EUR0.0223.831.1KOn
24 Apr 202658.53 EUR4.4%54.23 EUR52.51 EUR0.3514.971.8KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.